Sacubitril/valsartan in real-life clinical practice
Enregistré dans:
Auteur principal: | Yüksel Çavuşoğlu |
---|---|
Format: | article |
Langue: | EN TR |
Publié: |
KARE Publishing
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cf3f1f032c954c9fb59b5b68d0cef516 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
par: M Rizzo, et autres
Publié: (2020) -
Sacubitril/valsartan alleviates myocardial fibrosis in diabetic cardiomyopathy rats
par: Jiao Ai, et autres
Publié: (2021) -
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
par: Mauro Gori, et autres
Publié: (2021) -
Editorial
par: Hakan Alta, et autres
Publié: (2021) -
Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
par: M Rizzo, et autres
Publié: (2020)